drugset / Trial / NCT03665402
A Pharamcogenomic Study for Isoniazid According to NAT2 Polymorphism Status
Completed
16 enrolled
Seoul National University Hospital
Ministry of Health & Welfare, Korea · collab
RandomizedParallel-groupOpen-labelPrevention
Summary
A clinical trial to investigate the appropriate dose of isoniazid according to NAT2 polymorphism status in Korean subjects
Timeline
- Start
- 2018-05-13
- Primary completion
- 2018-12-31
- Completion
- 2019-03-31
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Isoniazid | Small molecule | 200 mg | — |
| Subject | Isoniazid | Small molecule | 300 mg | — |